Cargando…

Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma

BACKGROUND: Papillary thyroid cancer (PTC) is the most frequent thyroid tumor. The tissue inhibitor of metalloproteinase-3 (TIMP3) gene encodes a matrix metalloproteinases inhibitor that exerts a tumor suppressor role in several tumor types. TIMP3 is frequently downregulated in PTC by promoter methy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazzoni, M., Todoerti, K., Agnelli, L., Minna, E., Pagliardini, S., Di Marco, T., Borrello, M. G., Neri, A., Greco, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743531/ https://www.ncbi.nlm.nih.gov/pubmed/36503426 http://dx.doi.org/10.1186/s12935-022-02811-8

Ejemplares similares

miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma
por: Minna, Emanuela, et al.
Publicado: (2016)

Correction: miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma
por: Minna, Emanuela, et al.
Publicado: (2018)

PTX3 acts as an extrinsic oncosuppressor
por: Bonavita, Eduardo, et al.
Publicado: (2015)

Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer
por: Rubino, Marcello, et al.
Publicado: (2017)

Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screening
por: Anania, Maria Chiara, et al.
Publicado: (2015)

Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma
por: Minna, Emanuela, et al.
Publicado: (2020)

Senescent Thyrocytes, Similarly to Thyroid Tumor Cells, Elicit M2-like Macrophage Polarization In Vivo
por: Mazzoni, Mara, et al.
Publicado: (2021)

Intrinsic S phase checkpoint enforced by an antiproliferative oncosuppressor cytokine
por: Mallucci, Livio, et al.
Publicado: (2021)

A Commentary on “PTX3 is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer”
por: Di Virgilio, Francesco
Publicado: (2015)

FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration
por: Frattini, Véronique, et al.
Publicado: (2012)

Updates on HIPK2: a resourceful oncosuppressor for clearing cancer
por: D’Orazi, Gabriella, et al.
Publicado: (2012)

Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting
por: Mabeta, Peace
Publicado: (2018)

microRNA‐377‐3p downregulates the oncosuppressor T‐cadherin in colorectal adenocarcinoma cells
por: Di Palo, Armando, et al.
Publicado: (2021)

Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors
por: Minna, Emanuela, et al.
Publicado: (2023)

Oncosuppressor-Mutated Cells as a Liquid Biopsy Test for Cancer-Screening
por: Abdouh, Mohamed, et al.
Publicado: (2019)

Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism
por: Mazzoni, Mara, et al.
Publicado: (2019)

Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.
por: Viel, A., et al.
Publicado: (1992)

MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma
por: Zhang, Wen-jing, et al.
Publicado: (2019)

In Silico Characterization of miRNA and Long Non-Coding RNA Interplay in Multiple Myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2016)

RB1-mediated cell-autonomous and host-dependent oncosuppressor mechanisms in radiation-induced osteosarcoma
por: Kansara, Maya, et al.
Publicado: (2014)

KCTD15 inhibits the Hedgehog pathway in Medulloblastoma cells by increasing protein levels of the oncosuppressor KCASH2
por: Spiombi, Eleonora, et al.
Publicado: (2019)

Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer
por: Nuzzo, Silvia, et al.
Publicado: (2019)

DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective
por: Secchi, Massimiliano, et al.
Publicado: (2022)

The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy
por: Kasaian, Katayoon, et al.
Publicado: (2015)

A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs
por: Li Santi, Anna, et al.
Publicado: (2018)

Restoring the oncosuppressor activity of microRNA-34a in glioblastoma using a polyglycerol-based polyplex
por: Ofek, Paula, et al.
Publicado: (2016)

The many facets of miR‐223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response
por: Favero, Andrea, et al.
Publicado: (2021)

Direct Interaction of miRNA and circRNA with the Oncosuppressor p53: An Intriguing Perspective in Cancer Research
por: Bizzarri, Anna Rita, et al.
Publicado: (2021)

miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma
por: Minna, Emanuela, et al.
Publicado: (2014)

Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma
por: Shi, Y, et al.
Publicado: (1999)

A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2018)

MiR-221 Exacerbate Cell Proliferation and Invasion by Targeting TIMP3 in Papillary Thyroid Carcinoma
por: Diao, Yingbin, et al.
Publicado: (2017)

Co-regulatory Network of Oncosuppressor miRNAs and Transcription Factors for Pathology of Human Hepatic Cancer Stem Cells (HCSC)
por: Mohamed, Rania Hassan, et al.
Publicado: (2019)

Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation
por: Lionetti, Marta, et al.
Publicado: (2015)

The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies
por: Colombo, Carla, et al.
Publicado: (2015)

Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors
por: ZURAC, SABINA, et al.
Publicado: (2016)

An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma
por: Miyazaki, T, et al.
Publicado: (2004)

Targeting Non-Oncogene Addiction: Focus on Thyroid Cancer
por: Anania, Maria Chiara, et al.
Publicado: (2020)

Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas
por: Groft, L L, et al.
Publicado: (2001)

Levels of Circulating TIMP-2 and MMP2-TIMP2 Complex Are Decreased in Squamous Cervical Carcinoma
por: Anne, Talvensaari-Mattila, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fph5vgh65l1slh7ub7cssnkphh